Published in:

01-06-2009 | Clinical and Epidemiological Study

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

Authors: C. Torti, G. Lapadula, A. Antinori, T. Quirino, R. Maserati, F. Castelnuovo, F. Maggiolo, A. De Luca, G. Paraninfo, F. Antonucci, G. Migliorino, A. Lazzarin, G. Di Perri, G. Rizzardini, R. Esposito, G. Carosi

Published in: Infection | Issue 3/2009